Table 1.
Baseline patient characteristics for patients with HRQoL information.
| Variable | n | |
|---|---|---|
| Age (years) | 75.5 ± 7.2 | 177 |
| Male | 56% | 177 |
| New York Heart Association class I/II/III/IV | 0/112/63/2 | 177 |
| Medical history: | ||
| Ischaemic heart disease | 69% | 175 |
| Atrial fibrillation | 49% | 177 |
| Hypertension | 32% | 173 |
| Diabetes | 22% | 175 |
| Medications: | ||
| Beta-blocker | 50% | 177 |
| Angiotensin converting enzyme (ACE) inhibitor | 74% | 177 |
| Furosemide | 94% | 177 |
| Furosemide dose (mg/day) | 109 ± 198 | 177 |
| Clinical parameters: | ||
| Body mass index (kg/m2) | 26 ± 5 | 169 |
| Heart rate (bpm) | 86 ± 21 | 163 |
| Haemoglobin (g/l) | 132 ± 15 | 171 |
| Estimated glomerular filtration rate (ml/min) | 53 ± 20 | 173 |
| Systolic blood pressure (mm Hg) | 135 ± 25 | 176 |
| Diastolic blood pressure (mm Hg) | 80 ± 14 | 176 |
| Brain natriuretic peptide (ng/l) | 220 [96; 436] | 161 |
| Echocardiographic measures of systolic function: | ||
| Left ventricular ejection fraction (%) | 34 ± 11 | 171 |
| Left ventricular end-diastolic volume (ml) | 124 ± 58 | 171 |
| Left ventricular end-systolic volume (ml) | 85 ± 49 | 171 |
| Atrioventricular plane displacement (mm) | 6.6 ± 2.0 | 174 |
| HRQoL: | ||
| Emotional reactions | 18.4 ± 22.6 | 177 |
| Sleep | 32.8 ± 31.9 | 177 |
| Energy | 52.1 ± 39.1 | 177 |
| Pain | 14.0 ± 20.2 | 177 |
| Physical mobility | 28.4 ± 25.9 | 177 |
| Social isolation | 10.1 ± 18.0 | 177 |
HRQoL, health-related quality of life, where a score of 100 denotes the worst situation.
Data for 177 patients presented as mean values ± standard deviation (SD), median (interquartile range) or proportion, as appropriate; n denotes number of available observations.